Radiology Medical News about PET

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Quantification of Translocator Protein in the Human Brain with PET and a Novel Radioligand, 18F-PBR06
The Journal of Nuclear Medicine, 06/16/09

Fujimura Y et al. - 18F-PBR06 can quantify TSPOs in the healthy human brain using 120 min of image acquisition and concurrent measurements of radioligand in plasma. Although brain activity is likely contaminated with radiometabolites, the percentage contamination is thought to be small, because values of distribution volume are stable during 60–120 min and vary by less than 10%. 18F-PBR06 is a longer-lived and promising alternative to 11C-labeled radioligands to measure TSPOs as a biomarker of inflammation in the brain.

<< Previous
Placement of mandibular nerve block using computed tomography to...

Next >>
Kinetic analysis of 3'-deoxy-3'-18F-fluorothymidine in head and...

Positron emission tomography at the end of first-line therapy and during follow-up in patients with Hodgkin lymphoma: A retrospective study
Annals of Oncology, 11/11/09 Relevance Score: 96%%

Comparison of 18F-Fluoro-L-DOPA, 18F-Fluoro-Deoxyglucose, and 18F-Fluorodopamine PET and 123I-MIBG Scintigraphy in the Localization of Pheochromocytoma and Paraganglioma
Journal of Clinical Endocrinology and Metabolism, 11/12/09 Relevance Score: 93%%

Evaluation of gross tumor size using CT, 18F-FDG PET, integrated 18F-FDG PET/CT and pathological analysis in non-small cell lung cancer
European Journal of Radiology, 10/26/09 Relevance Score: 92%%

Hodgkin's lymphoma in remission after first-line therapy: Which patients need FDG-PET/CT for follow-up?
Annals of Oncology, 11/17/09 Relevance Score: 91%%

Miscellaneous Cancers (Lung, Thyroid, Renal Cancer, Myeloma, and Neuroendocrine Tumors): Role of SPECT and PET in Imaging Bone Metastases
Seminars in Nuclear Medicine, 10/14/09 Relevance Score: 90%%